Mani Foroohar

Mani Foroohar

Analyst-Equity bij Leerink Partners LLC

Finance
Consumer Services

Profiel

Dr. Mani Foroohar is a Senior Managing Director of Genetic Medicines at Leerink Partners LLC.
He is also a Senior Research Analyst within the Therapeutics team focusing on Genetic Medicines.
Dr. Foroohar joins Leerink from Aptigon Capital, a Citadel Company, where he most recently was a Therapeutics Analyst focused on U.S.
and EU biotechnology, major pharmaceuticals and specialty pharmaceuticals sectors.
Prior to Aptigon, he was an Analyst at Green Owl Capital Management and an Assistant Vice President of Equity Research at Barclays.
In 2013, he co-founded Cellanyx Diagnostics, a company developing a proprietary live tumor cell, phenotypic platform for precision risk stratification in cancer to inform clinical treatment decision making.
Dr. Foroohar holds an M.D.
from Stanford, where he was a Howard Hughes Medical Institute Research Fellow in the Department of Genetics, M.B.A.
from Columbia, and a B.S.
from UCLA.

Actieve functies van Mani Foroohar

BedrijvenFunctieBegin
Analyst-Equity 01-05-2018
Alle actieve functies van Mani Foroohar

Eerdere bekende functies van Mani Foroohar

BedrijvenFunctieEinde
Analyst-Equity 01-12-2014
Analyst-Equity -
Ervaring van Mani Foroohar in detail bekijken

Opleiding van Mani Foroohar

University of California, Los Angeles Undergraduate Degree
Stanford University School of Medicine Doctorate Degree
Columbia Business School Masters Business Admin

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Mani Foroohar in detail bekijken

Connecties

100 +

Eerstegraads connecties

6

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Bedrijven in privébezit3

Finance

Finance

Finance

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Mani Foroohar